entete

Bogdan CATARGI
PUBLICATIONS

A. Ravaud, C. de la Fouchardiere, P. Caron, A. Doussau, C. Do Cao, J. Asselineau, P. Rodien, D. Pouessel, P. Nicolli-Sire, M. Klein, C. Bournaud-Salinas, J.L. Wemeau, A. Gimbert, M.Q. Picat, D. Pedenon, L. Digue, A. Daste, B. Catargi, J.P. Delord, A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study, Eur J Cancer, 76 (2017) 110-117.

B. Neal, V. Perkovic, K.W. Mahaffey, D. de Zeeuw, G. Fulcher, N. Erondu, W. Shaw, G. Law, M. Desai, D.R. Matthews, Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes, N Engl J Med, 377 (2017) 644-657.

D. Taieb, C. Bournaud, M.C. Eberle, B. Catargi, C. Schvartz, M.B. Cavarec, I. Faugeron, M.E. Toubert, D. Benisvy, C. Archange, O. Mundler, P. Caron, A.E. Abdullah, K. Baumstarck, Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves' hyperthyroidism undergoing radioiodine therapy: a randomized controlled study, Eur J Endocrinol, 174 (2016) 491-502.

S. Lassalle, J. Zangari, A. Popa, M. Ilie, V. Hofman, E. Long, M. Patey, F. Tissier, G. Belleannee, H. Trouette, B. Catargi, I. Peyrottes, J.L. Sadoul, O. Bordone, C. Bonnetaud, C. Butori, A. Bozec, N. Guevara, J. Santini, I.S. Henaoui, G. Lemaire, O. Blanck, P. Vielh, P. Barbry, B. Mari, P. Brest, P. Hofman, MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib, Oncotarget, 7 (2016) 30461-30478.

S. Denisov, F. Pinaud, M. Chambaud, V. Lapeyre, B. Catargi, N. Sojic, N. McClenaghan, V. Ravaine, Saccharide-induced modulation of photoluminescence lifetime in microgels, Physical Chemistry Chemical Physics, 18 (2016) 16812-16821.

Verges, B. Patois-Verges, M.C. Iliou, I. Simoneau-Robin, J.H. Bertrand, J.M. Feige, H. Douard, B. Catargi, M. Fischbach, Influence of glycemic control on gain in VO2 peak, in patients with type 2 diabetes enrolled in cardiac rehabilitation after an acute coronary syndrome. The prospective DARE study, BMC Cardiovasc Disord, 15 (2015) 64.

F. Pinaud, R. Millereux, P. Vialar-Trarieux, B. Catargi, S. Pinet, I. Gosse, N. Sojic, V. Ravaine, Differential Photoluminescent and Electrochemiluminescent Behavior for Resonance Energy Transfer Processes in Thermoresponsive Microgels, J Phys Chem B, 119 (2015) 12954-12961.

M.A. Pfeffer, B. Claggett, R. Diaz, K. Dickstein, H.C. Gerstein, L.V. Kober, F.C. Lawson, L. Ping, X. Wei, E.F. Lewis, A.P. Maggioni, J.J. McMurray, J.L. Probstfield, M.C. Riddle, S.D. Solomon, J.C. Tardif, Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome, N Engl J Med, 373 (2015) 2247-2257.

F. Lebreton, A. Pirog, I. Belouah, D. Bosco, T. Berney, P. Meda, Y. Bornat, B. Catargi, S. Renaud, M. Raoux, Slow potentials encode intercellular coupling and insulin demand in pancreatic beta cells, Diabetologia, 58 (2015) 1291-1299.

M. Joubert, S. Baillot-Rudoni, B. Catargi, G. Charpentier, A. Esvant, S. Franc, B. Guerci, I. Guilhem, V. Melki, E. Merlen, Indication, organization, practical implementation and interpretation guidelines for retrospective CGM recording: A French position statement, Diabetes & metabolism, 41 (2015) 498-508.

I. Borget, J. Bonastre, B. Catargi, D. Déandréis, S. Zerdoud, D. Rusu, S. Bardet, L. Leenhardt, D. Bastie, C. Schvartz, Quality of life and cost-effectiveness assessment of radioiodine ablation strategies in patients with thyroid cancer: results from the randomized phase III ESTIMABL trial, Journal of Clinical Oncology, 33 (2015) 2885-2892.

D. Tarus, E. Hachet, L. Messager, B. Catargi, V. Ravaine, R. Auzély‐Velty, Readily Prepared Dynamic Hydrogels by Combining Phenyl Boronic Acid‐and Maltose‐Modified Anionic Polysaccharides at Neutral pH, Macromolecular rapid communications, 35 (2014) 2089-2095.

P. Schaepelynck, J.-P. Riveline, E. Renard, H. Hanaire, B. Guerci, S. Baillot-Rudoni, A. Sola-Gazagnes, B. Catargi, P. Fontaine, L. Millot, Assessment of a new insulin preparation for implanted pumps used in the treatment of type 1 diabetes, Diabetes technology & therapeutics, 16 (2014) 582-589.

S. Renaud, B. Catargi, J. Lang, Biosensors in Diabetes: How to get the most out of evolution and transpose it into a signal, IEEE pulse, 5 (2014) 30-34.

F. Pinaud, K. Geisel, P. Massé, B. Catargi, L. Isa, W. Richtering, V. Ravaine, V. Schmitt, Adsorption of microgels at an oil–water interface: correlation between packing and 2D elasticity, Soft Matter, 10 (2014) 6963-6974.

L. Messager, N. Portecop, E. Hachet, V. Lapeyre, I. Pignot-Paintrand, B. Catargi, R. Auzély-Velty, V. Ravaine, Photochemical crosslinking of hyaluronic acid confined in nanoemulsions: towards nanogels with a controlled structure, Journal of Materials Chemistry B, 1 (2013) 3369-3379.

B. Verges, A. Avignon, F. Bonnet, B. Catargi, S. Cattan, E. Cosson, G. Ducrocq, M. Elbaz, A. Fredenrich, P. Gourdy, Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome, Diabetes & metabolism, 38 (2012) 113-127.

M. Schlumberger, B. Catargi, I. Borget, D. Deandreis, S. Zerdoud, B. Bridji, S. Bardet, L. Leenhardt, D. Bastie, C. Schvartz, P. Vera, O. Morel, D. Benisvy, C. Bournaud, F. Bonichon, C. Dejax, M.E. Toubert, S. Leboulleux, M. Ricard, E. Benhamou, Strategies of radioiodine ablation in patients with low-risk thyroid cancer, N Engl J Med, 366 (2012) 1663-1673.

J.-P. Riveline, P. Schaepelynck, L. Chaillous, E. Renard, A. Sola-Gazagnes, A. Penfornis, N. Tubiana-Rufi, V. Sulmont, B. Catargi, C. Lukas, Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens, Diabetes Care, 35 (2012) 965-971.

M. Raoux, Y. Bornat, A. Quotb, B. Catargi, S. Renaud, J. Lang, Non‐invasive long‐term and real‐time analysis of endocrine cells on micro‐electrode arrays, The Journal of physiology, 590 (2012) 1085-1091.

H.C. Gerstein, J. Bosch, G.R. Dagenais, R. Diaz, H. Jung, A.P. Maggioni, J. Pogue, J. Probstfield, A. Ramachandran, M.C. Riddle, L.E. Ryden, S. Yusuf, Basal insulin and cardiovascular and other outcomes in dysglycemia, N Engl J Med, 367 (2012) 319-328.

D. des Techniques, J. Selam, D. Selam, J. Bringer, B. Catargi, B. Charbonnel, G. Charpentier, H. Gin, B. Guerci, M. Haardt, INFUSYSTEMES FRANCE. INFUS, J Diabetes Sci Technol, 4 (2012) 1400-1407.

J. Bosch, H.C. Gerstein, G.R. Dagenais, R. Diaz, L. Dyal, H. Jung, A.P. Maggiono, J. Probstfield, A. Ramachandran, M.C. Riddle, L.E. Ryden, S. Yusuf, n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia, N Engl J Med, 367 (2012) 309-318.

P.-Y. Benhamou, B. Catargi, B. Delenne, B. Guerci, H. Hanaire, N. Jeandidier, R. Leroy, L. Meyer, A. Penfornis, R.-P. Radermecker, Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE, Diabetes & metabolism, 38 (2012) S67-S83.

P. Schaepelynck, E. Renard, N. Jeandidier, H. Hanaire, C. Fermon, S. Rudoni, B. Catargi, J.-P. Riveline, B. Guerci, L. Millot, A recent survey confirms the efficacy and the safety of implanted insulin pumps during long-term use in poorly controlled type 1 diabetes patients, Diabetes technology & therapeutics, 13 (2011) 657-660.

G. Charpentier, P.-Y. Benhamou, D. Dardari, A. Clergeot, S. Franc, P. Schaepelynck-Belicar, B. Catargi, V. Melki, L. Chaillous, A. Farret, The diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves hba1c in poorly controlled type 1 diabetic patients, Diabetes care, 34 (2011) 533-539.

C. Ancla, V. Lapeyre, I. Gosse, B. Catargi, V. Ravaine, Designed glucose-responsive microgels with selective shrinking behavior, Langmuir, 27 (2011) 12693-12701.

A. Ravaud, C. de la Fouchardière, J. Asselineau, J.-P. Delord, C. Do Cao, P. Niccoli, P. Rodien, M. Klein, B. Catargi, Efficacy of sunitinib in advanced medullary thyroid carcinoma: intermediate results of phase II THYSU, The oncologist, 15 (2010) 212-213.

A. Ravaud, C. De la Fouchardière, F. Courbon, J. Asselineau, M. Klein, P. Nicoli-Sire, C. Bournaud, J. Delord, G. Weryha, B. Catargi, Sunitinib in patients with refractory advanced thyroid cancer: the THYSU phase II trial, Journal of Clinical Oncology, 26 (2008) 6058-6058.

V. Ravaine, C. Ancla, B. Catargi, Chemically controlled closed-loop insulin delivery, Journal of Controlled Release, 132 (2008) 2-11.

V. Lapeyre, C. Ancla, B. Catargi, V. Ravaine, Glucose-responsive microgels with a core–shell structure, Journal of colloid and interface science, 327 (2008) 316-323.

N. Jeandidier, J.-P. Riveline, N. Tubiana-Rufi, A. Vambergue, B. Catargi, V. Melki, G. Charpentier, B. Guerci, Treatment of diabetes mellitus using an external insulin pump in clinical practice, Diabetes & metabolism, 34 (2008) 425-438.

A.S. Cunha, C. Beau, A. Rault, B. Catargi, D. Collet, B. Masson, Laparoscopic versus open approach for solitary insulinoma, Surgical endoscopy, 21 (2007) 103-108.

A. Tabarin, Y. Diz-Chaves, M. Carmona, B. Catargi, E. Zorrilla, A. Roberts, D. Coscina, S. Rousset, A. Redonnet, G. Parker, Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: evidence for a" thrifty gene". DIABETES, 55 (2006) 862-862.

A. Tabarin, Y. Diz-Chaves, M. del Carmen Carmona, B. Catargi, E.P. Zorrilla, A.J. Roberts, D.V. Coscina, S. Rousset, A. Redonnet, G.C. Parker, Resistance to Diet-Induced Obesity in μ-Opioid Receptor–Deficient Mice, Diabetes, 54 (2005) 3510-3516.

B. Gatta, D.H. Hau, B. Catargi, P. Roger, A. Tabarin, Re-evaluation of the efficacy of the association of cabergoline to somatostatin analogues in acromegalic patients, Clinical endocrinology, 63 (2005) 477.

Catargi, Current status and future of implantable insulin pumps for the treatment of diabetes, Expert review of medical devices, 1 (2004) 181-185.

M. Ries, F. Basseau, B. Tyndal, R. Jones, C. Deminière, B. Catargi, C. Combe, C.W. Moonen, N. Grenier, Renal diffusion and BOLD MRI in experimental diabetic nephropathy, Journal of Magnetic Resonance Imaging, 17 (2003) 104-113.

H. Gin, E. Renard, V. Melki, S. Boivin, P. Schaepelynck-Belicar, B. Guerci, J. Selam, J. Brun, J. Riveline, B. Estour, Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience, Diabetes & metabolism, 29 (2003) 602-607.

B. Catargi, V. Rigalleau, A. Poussin, N. Ronci-Chaix, V. Bex, V. Vergnot, H. Gin, P. Roger, A. Tabarin, Occult Cushing’s syndrome in type-2 diabetes, The Journal of Clinical Endocrinology & Metabolism, 88 (2003) 5808-5813.

B. Catargi, M. Monsaingeon, V. Bex-Bachellerie, N. Ronci-Chaix, H. Trouette, A. Margotat, A. Tabarin, P. Beck-Peccoz, A novel thyroid hormone receptor-beta mutation, not anticipated to occur in resistance to thyroid hormone, causes variable phenotypes, Hormone Research in Paediatrics, 57 (2002) 137-142.

N. Valli, B. Catargi, N. Ronci, V. Vergnot, F. Leccia, J. Ferriere, G. Chene, N. Grenier, F. Laurent, A. Tabarin, Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas, European Journal of Endocrinology, 144 (2001) 401-408.

H. Gin, V. Melki, B. Guerci, B. Catargi, Clinical evaluation of a newly designed compliant side port catheter for an insulin implantable pump, Diabetes Care, 24 (2001) 175-175.

B. Catargi, D. Breilh, H. Gin, V. Rigalleau, M. Saux, P. Roger, A. Tabarin, Etude comparative du controle glycemique et du risque d'hypoglycemie obtenus par pompe a insuline non programmable et programmable, Diabetes and Metabolism, 27 (2001) 323-328.

B. Catargi, D. Breilh, P. Roger, A. Tabarin, Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump, Diabetes & metabolism, 26 (2000) 210-214.

C. Bonnin, B. Gatta, B. Fremy, V. Bachellerie, N. Ronci, M. Duclos, M. Grino, B. Masson, B. Catargi, A. Tabarin, Acromegaly caused by ectopic growth hormone-releasinghormone secretion, Growth Hormone & IGF Research, 10 (2000) S157.

N. Valli, B. Catargi, N. Ronci, F. Leccia, M. Guyot, P. Roger, D. Ducassou, A. Tabarin, Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy, Thyroid, 9 (1999) 583-589.

A. Tabarin, N. Valli, P. Chanson, Y. Bachelot, V. Rohmer, V. Bex-Bachellerie, B. Catargi, P. Roger, F. Laurent, Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome, The Journal of Clinical Endocrinology & Metabolism, 84 (1999) 1193-1202.

B. Catargi, J. Raymond, V. Lafarge-Gense, F. Leccia, P. Roger, A. Tabarin, Localization of parathyroid tumors using endoscopic ultrasonography in primary hyperparathyroidism, Journal of endocrinological investigation, 22 (1999) 688-692.

B. Catargi, F. Parrot-Roulaud, C. Cochet, D. Ducassou, P. Roger, A. Tabarin, Homocysteine, hypothyroidism, and effect of thyroid hormone replacement, Thyroid, 9 (1999) 1163-1166.

B. Catargi, F. Leprat, M. Guyot, N. Valli, D. Ducassou, A. Tabarin, Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome, European journal of endocrinology, 141 (1999) 117-121.

B. Catargi, E. Felicie-Dellan, A. Tabarin, Comment on gonadotroph adenoma causing ovarian hyperstimulation, The Journal of Clinical Endocrinology & Metabolism, 84 (1999) 3404-3404.

A. Tabarin, F. Laurent, B. Catargi, F. Olivier‐Puel, R. Lescene, J. Berge, F. San Galli, J. Drouillard, P. Roger, J. Guerin, Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease, Clinical endocrinology, 49 (1998) 293-300.

H. Gin, B. Catargi, V. Rigalleau, E. Rullier, P. Roger, A. Tabarin, Experience with the Biostator for diagnosis and assisted surgery of 21 insulinomas, European journal of endocrinology, 139 (1998) 371-377.

A. Tabarin, B. Catargi, P. Chanson, S. Hieronimus, J.B. Corcuff, F. Laurent, M. Harter, J. Drouillard, P. Roger, Pseudo‐tumours of the thymus after correction of hypercortisolism in patients with ectopic ACTH syndrome: a report of five cases, Clinical endocrinology, 42 (1995) 207-213.

 

PATENTS

R. Auzely-Velty, E. Hachet, B. Catargi, V. Ravaine and L. Messager; 2017; Glucose responsive hydrogel comprising PBA-grafted hyaluronic acid (HA); US Patent 9,549,987 

J. Lang, B. Catargi, M. Raoux, S. Renaud, G. Charpentier and Y. Bornat; 2010; Sensor for measuring the activity of beta-pancreatic cells or of islets of Langerhans, manufacture and use of such a sensor; WO2011EP50359 20110112; BR20121117440 20110112; 2016/04/19/; AU2011206641 (A1)   AU2011206641 (A8)   AU2011206641 (B2)   CA2787302 (A1)   CN102933143 (A)   CN102933143 (B)   EP2523595 (A1)   FR2955179 (A1)   IL220923 (A)   JP2013517029 (A)   JP5715160 (B2)   KR20120120299 (A)   MX2012008129 (A)   US2013030271 (A1)   WO2011086105 (A1)